Acyl amino acid derivatives as novel inhibitors of influenza neuraminidase. 1997

M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
Department of Bioapplied Chemistry, Osaka City University, Japan.

We searched our chemical collection to identify non-N-acetylneuraminate (NeuAC) inhibitors of influenza neuraminidase (NA). Of the 62 acyl derivatives tested, several acyl amino acids, but not acyl alkanolamine derivatives, were effective and inhibited the NA activity in a dose-dependent manner. N-3-Hydroxymyristoyl D-cysteine and N-myristoyl-O-caproyl-D-serine were the more potent compounds and inhibited the enzyme in a noncompetitive manner (Ki = 102 and 125 microM, respectively) without respect to the substrate. An important consideration for the choice of inhibitor is the selectivity of the inhibition. These compounds were selective inhibitors of viral NA and effective for any variant enzyme, but the enzymes from V. cholerae and human placenta were insensitive. Accordingly, the acyl amino acid derivatives may be expected to be inhibitors without cellular toxicity and may serve as lead compounds for anti-influenza agents.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000215 Acylation The addition of an organic acid radical into a molecule.
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
December 2014, Bioorganic & medicinal chemistry,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
December 2013, Bioorganic & medicinal chemistry,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
January 2020, Archiv der Pharmazie,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
September 2001, Antimicrobial agents and chemotherapy,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
June 2016, Journal of medicinal chemistry,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
April 2011, Bioorganic & medicinal chemistry,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
August 2011, Journal of enzyme inhibition and medicinal chemistry,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
March 2016, Archiv der Pharmazie,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
January 2020, Frontiers in microbiology,
M Kondoh, and T Furutani, and M Azuma, and H Ooshima, and J Kato
June 2013, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!